Premarket Mover: RedHill Biopharma Ltd (RDHL) Down 21.53%

RedHill Biopharma Ltd (RDHL) is down Thursday morning, with the stock declining -21.53% in pre-market trading to 2.26. RDHL's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 125 out of 146 industries, the stock ranks higher than 100% of stocks. RedHill Biopharma Ltd has risen 487.76% over the past month, closing at $0.40 on November 2. During this period of time, the stock fell as low as $0.31 and as high as $2.79.

RDHL has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on RDHL!

See Full RDHL Report

RedHill Biopharma Ltd has a Long-Term Technical rank of 100. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 0% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 109 by this metric, RDHL ranks better than 109% of stocks.

Important Dates for Investors in RDHL:

-RedHill Biopharma Ltd is set to release earnings on 2023-12-05. Over the last 12 months, the company has reported EPS of $0.12. -We do not have a set dividend date for RedHill Biopharma Ltd at this time. Click Here To Get The Full Report on RedHill Biopharma Ltd (RDHL)